Reliability of a New Recombinant Immunoblot Assay (RIBA HIV-1/HIV-2 SIA) as a Supplemental (Confirmatory) Test for HIV-1 and HIV-2 Infections

By Mas A.   Soriano V.   Gutierrez M.   Fumanal F.   Alonso A.   Gonzalez-Lahoz J.  

Transfusion and Apheresis Science, Vol. 18, Iss. 1, 1997-03 ,pp. : 63-69

Elsevier

Access to resources Recommend Favorite

Effect of IL-2 Therapy on CD8⁺ Cell Noncytotoxic Anti-HIV Response During Primary HIV-1 Infection

By Martinez-Mariño B.   Ashlock B. M.   Shiboski S.   Hecht F. M.   Levy J. A.  

Journal of Clinical Immunology, Vol. 24, Iss. 2, 2004-03 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals

By Ansari Abdul Wahid   Bhatnagar Nupur   Dittrich-Breiholz Oliver   Kracht Michael   Schmidt Reinhold E.   Heiken Hans  

International Immunology, Vol. 18, Iss. 10, 2006-10 ,pp. : 1443-1451

Oxford University Press

Access to resources Recommend Favorite

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

By Clarke David   Cooper David   Egan Michael   Hendry R.   Parks Christopher   Udem Stephen  

Springer Seminars in Immunopathology, Vol. 28, Iss. 3, 2006-11 ,pp. : 239-253

Springer Publishing Company

Access to resources Recommend Favorite

Anti-HIV-1 Gene Therapy

By Medina M.   Ramezani A.   Joshi S.  

Transfusion and Apheresis Science, Vol. 17, Iss. 1, 1996-03 ,pp. : 109-120

Elsevier

Access to resources Recommend Favorite